Basic pharmacology of some glaucoma drugs with emphasis on new information and new developments.
This paper will discuss the pharmacology and mechanism of action of various drugs used to treat glaucoma, such as epinephrine, pilocarpine, carbonic anhydrase inhibitors and a new class of drugs to be used in ophthalmology, the beta adrenergic blockers, with particular reference to timolol.
D000086:Acetazolamide / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists; D001711:Biotransformation; D002217:Carbachol / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors; D004837:Epinephrine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D008704:Methazolamide / Q000627:therapeutic use*; D011412:Propanolamines / Q000627:therapeutic use*; D013830:Thiadiazoles / Q000627:therapeutic use*; D013999:Timolol / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors; D011412:Propanolamines; D013830:Thiadiazoles; D013999:Timolol; C015173:dipivefrin; D002217:Carbachol; D000086:Acetazolamide; D008704:Methazolamide; C016348:N-demethylcarbachol; D004837:Epinephrine